Schedule 13G: Akre Entities Own 3.72M SOPHiA GENETICS Shares

Rhea-AI Filing Summary

Schedule 13G filing: On 27 June 2025 Akre Capital Management, LLC (ACM), Braddock Partners Offshore, LP and Braddock Capital Offshore, LLC jointly filed a Schedule 13G reporting a beneficial position in SOPHiA GENETICS SA (CUSIP H82027105).

The reporting persons collectively hold 3,719,140 ordinary shares, representing 5.6 % of the outstanding class. All voting and dispositive authority over the shares is shared; each entity reports zero sole voting or dispositive power and full shared power over the entire stake, triggering the 5 % disclosure threshold under Section 13(d).

ACM is organized in Delaware and operates as an investment adviser, while Braddock Partners Offshore, LP is a Cayman Islands limited partnership and Braddock Capital Offshore, LLC is a Delaware limited-liability company. The certification states that the securities were acquired ‘not for the purpose of or with the effect of changing or influencing the control’ of the issuer. No additional group members, subsidiary acquisitions, or 5 %-or-less disclaimers are indicated. An Exhibit A Joint Filing Agreement accompanies the submission.

Positive

• Akre Capital Management and its affiliates have accumulated 3.72 million shares (5.6 %) of SOPHiA GENETICS, confirming meaningful institutional ownership.

Negative

• None.

Insights

Securities Analyst

Akre-led group reveals 5.6 % SOPH stake; disclosure appears strategically passive.

The filing confirms that ACM and related offshore vehicles now control 3.72 million SOPHiA GENETICS shares. The stake crosses the 5 % threshold but remains far from a controlling level, and the certification expressly disclaims any intent to influence control. Because voting and dispositive power are shared and no additional action is signalled, the market impact is likely limited to heightened institutional visibility. Investors may view the involvement of a professional investment adviser positively, yet the passive nature of the filing provides no direct insight into near-term operating performance or strategic change.

Corporate Governance Expert

Passive 13G indicates institutional ownership with no governance change expected.

This Schedule 13G is a routine disclosure of a >5 % holding by three related entities under common management. The absence of sole voting power and the explicit statement that the securities are not held to influence control suggest a purely passive investment. From a governance perspective, the issuer’s board and existing shareholders face no immediate threat of activism. Nonetheless, a single group now controls a non-trivial block, which could become influential in future governance votes should their intentions evolve, but nothing in the filing indicates such a plan.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

SOPHiA GENETICS SA

(Name of Issuer)

Ordinary Shares, par value CHF 0.05 per share

(Title of Class of Securities)

H82027105

(CUSIP Number)

06/20/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. H82027105

1

Names of Reporting Persons

AKRE CAPITAL MANAGEMENT, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 3,719,140.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 3,719,140.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

3,719,140.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.6 %

12

Type of Reporting Person (See Instructions)

IA, OO

SCHEDULE 13G

CUSIP No. H82027105

1

Names of Reporting Persons

Braddock Partners Offshore, LP

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

CAYMAN ISLANDS

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 3,719,140.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 3,719,140.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

3,719,140.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.6 %

12

Type of Reporting Person (See Instructions)

PN

SCHEDULE 13G

CUSIP No. H82027105

1

Names of Reporting Persons

Braddock Capital Offshore, LLC

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 3,719,140.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 3,719,140.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

3,719,140.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.6 %

12

Type of Reporting Person (See Instructions)

OO

SCHEDULE 13G

Item 1.
(a)	Name of issuer: SOPHiA GENETICS SA
(b)	Address of issuer's principal executive offices: 401 Park Drive Suite 505, Boston, Massachusetts 02215, United States of America
Item 2.
(a)	Name of person filing: Akre Capital Management, LLC Braddock Partners Offshore, LP Braddock Capital Offshore, LLC
(b)	Address or principal business office or, if none, residence: Akre Capital Management, LLC 2 West Marshall Street P.O. Box 998 Middleburg, Virginia 20118-0998 United States of America Braddock Partners Offshore, LP c/o Akre Capital Management, LLC 2 West Marshall Street P.O. Box 998 Middleburg, Virginia 20118-0998 United States of America Braddock Capital Offshore, LLC c/o Akre Capital Management, LLC 2 West Marshall Street P.O. Box 998 Middleburg, Virginia 20118-0998 United States of America
(c)	Citizenship: Akre Capital Management, LLC - Delaware Braddock Partners Offshore, LP - Cayman Islands Braddock Capital Offshore, LLC - Delaware
(d)	Title of class of securities: Ordinary Shares, par value CHF 0.05 per share
(e)	CUSIP No.: H82027105
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: Akre Capital Management, LLC - 3,719,140 Braddock Partners Offshore, LP - 3,719,140 Braddock Capital Offshore, LLC - 3,719,140
(b)	Percent of class: Akre Capital Management, LLC - 5.6% Braddock Partners Offshore, LP - 5.6% Braddock Capital Offshore, LLC - 5.6%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: Akre Capital Management, LLC - 0 Braddock Partners Offshore, LP - 0 Braddock Capital Offshore, LLC - 0
	(ii) Shared power to vote or to direct the vote: Akre Capital Management, LLC - 3,719,140 Braddock Partners Offshore, LP - 3,719,140 Braddock Capital Offshore, LLC - 3,719,140
	(iii) Sole power to dispose or to direct the disposition of: Akre Capital Management, LLC - 0 Braddock Partners Offshore, LP - 0 Braddock Capital Offshore, LLC - 0
	(iv) Shared power to dispose or to direct the disposition of: Akre Capital Management, LLC - 3,719,140 Braddock Partners Offshore, LP - 3,719,140 Braddock Capital Offshore, LLC - 3,719,140
Item 5.	Ownership of 5 Percent or Less of a Class.
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

AKRE CAPITAL MANAGEMENT, LLC

Signature:	By: /s/ Charles T. Akre, Jr.*
Name/Title:	Charles T. Akre, Jr./Managing Member
Date:	06/27/2025

Braddock Partners Offshore, LP

Signature:	By: Braddock Capital Offshore, LLC, its general partner, By: /s/ Charles T. Akre, Jr.*
Name/Title:	Charles T. Akre, Jr./Managing Member
Date:	06/27/2025

Braddock Capital Offshore, LLC

Signature:	By: /s/ Charles T. Akre, Jr.*
Name/Title:	Charles T. Akre, Jr./Managing Member
Date:	06/27/2025

Comments accompanying signature: * Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his, her or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Exhibit Information

Exhibit A - Joint Filing Agreement

FAQ

Who filed the Schedule 13G for SOPHiA GENETICS (SOPH) dated 27 June 2025?

The filing was made jointly by Akre Capital Management, LLC, Braddock Partners Offshore, LP, and Braddock Capital Offshore, LLC.

How many SOPHiA GENETICS shares are reported in the filing?

The reporting persons beneficially own 3,719,140 ordinary shares.

What percentage of SOPHiA GENETICS’ outstanding shares does this represent?

The disclosed stake equals 5.6 % of the outstanding class.

Do the reporting persons have sole or shared voting power over these shares?

They report 0 shares with sole voting power and 3,719,140 shares with shared voting power.

What is the event date that triggered the Schedule 13G filing?

The triggering event occurred on 20 June 2025.

Where is SOPHiA GENETICS’ principal executive office located?

The company’s principal office is at 401 Park Drive Suite 505, Boston, MA 02215, USA.